Jeffrey Hung's Stock Ratings

Morgan Stanley Analyst

Jeffrey Hung is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-0.39%

Smart Score

53.3%

Overall Average Return Percentile

34th

Number of Ratings

118
Buy NowGet Alert
05/10/2024FOLDBuy Now
Amicus Therapeutics
$9.7594.87%$20 → $19MaintainsOverweightGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$15.0166.56% → $25Initiates → OverweightGet Alert
04/29/2024PTCTBuy Now
PTC Therapeutics
$39.99-24.98%$28 → $30UpgradeUnderweight → Equal-WeightGet Alert
04/02/2024IRONBuy Now
Disc Medicine
$32.3723.57%$75 → $40MaintainsEqual-WeightGet Alert
03/13/2024ACADBuy Now
ACADIA Pharmaceuticals
$15.1598.02%$40 → $30MaintainsOverweightGet Alert
03/08/2024ENGNBuy Now
enGene Holdings
$14.50175.86% → $40Initiates → OverweightGet Alert
02/20/2024CGONBuy Now
CG Oncology
$29.7385% → $55Initiates → OverweightGet Alert
01/16/2024CRNXBuy Now
Crinetics Pharmaceuticals
$50.62-1.22% → $50Initiates → OverweightGet Alert
01/05/2024CYTKBuy Now
Cytokinetics
$60.0549.88%$60 → $90DowngradeOverweight → Equal-WeightGet Alert
12/22/2023KRTXBuy Now
Karuna Therapeutics
$295 → $330DowngradeOverweight → Equal-WeightGet Alert
12/19/2023PTCTBuy Now
PTC Therapeutics
$39.99-29.98% → $28DowngradeEqual-Weight → UnderweightGet Alert
12/19/2023PRLDBuy Now
Prelude Therapeutics
$4.12-2.91%$10 → $4DowngradeEqual-Weight → UnderweightGet Alert
12/19/2023VIGLBuy Now
Vigil Neuroscience
$3.4814.94%$13 → $4DowngradeEqual-Weight → UnderweightGet Alert
12/19/2023IRONBuy Now
Disc Medicine
$32.37100.8%$56 → $65DowngradeOverweight → Equal-WeightGet Alert
12/19/2023RYTMBuy Now
Rhythm Pharmaceuticals
$38.8741.51%$29 → $55UpgradeEqual-Weight → OverweightGet Alert
12/19/2023IVVDBuy Now
Invivyd
$2.4563.27%$1 → $4UpgradeUnderweight → Equal-WeightGet Alert
12/19/2023FOLDBuy Now
Amicus Therapeutics
$9.75105.13%$15 → $20UpgradeEqual-Weight → OverweightGet Alert
12/19/2023ACADBuy Now
ACADIA Pharmaceuticals
$15.15164.03%$31 → $40UpgradeEqual-Weight → OverweightGet Alert
12/08/2023BLUEBuy Now
bluebird bio
$1.04573.08%$3 → $7UpgradeUnderweight → Equal-WeightGet Alert
11/03/2023RAREBuy Now
Ultragenyx Pharmaceutical
$40.64106.69%$90 → $84MaintainsOverweightGet Alert
11/03/2023BCYCBuy Now
Bicycle Therapeutics
$21.3687.27%$42 → $40MaintainsEqual-WeightGet Alert
11/03/2023ACADBuy Now
ACADIA Pharmaceuticals
$15.15104.62%$30 → $31MaintainsEqual-WeightGet Alert
10/27/2023PTCTBuy Now
PTC Therapeutics
$39.99-29.98%$31 → $28MaintainsEqual-WeightGet Alert
10/10/2023RAREBuy Now
Ultragenyx Pharmaceutical
$40.64121.46%$95 → $90MaintainsOverweightGet Alert
10/10/2023RYTMBuy Now
Rhythm Pharmaceuticals
$38.87-25.38%$28 → $29MaintainsEqual-WeightGet Alert
09/18/2023PTCTBuy Now
PTC Therapeutics
$39.99-22.48%$47 → $31MaintainsEqual-WeightGet Alert
08/04/2023RAREBuy Now
Ultragenyx Pharmaceutical
$40.64133.76%$95 → $95ReiteratesOverweight → OverweightGet Alert
08/04/2023PTCTBuy Now
PTC Therapeutics
$39.9917.53%$47 → $47ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023PRLDBuy Now
Prelude Therapeutics
$4.12142.72%$10 → $10ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023KRTXBuy Now
Karuna Therapeutics
$280 → $280ReiteratesOverweight → OverweightGet Alert